Independent notes on the drug everyone is about to search.

Lily Retatrutide tracks public evidence around Eli Lilly's investigational retatrutide and the Australian market that forms around it.

The site is not Eli Lilly. It is not a clinic. It is not medical advice. It is a plain-English editorial layer for readers who want to separate trial data, approval status, and seller evidence.